LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE
74th Regular Session
April 17, 1995
TO: Honorable Hugo Berlanga, Chair IN RE: House Bill No. 2838
Committee on Public Health By: Maxey
House of Representatives
Austin, Texas
FROM: John Keel, Director
In response to your request for a Fiscal Note on House Bill No.
2838 (Relating to the powers and duties of the Texas Department
of Health under the Texas Food, Drug, and Cosmetic Act.) this
office has determined the following:
The bill would modify provisions in the Texas Food, Drug, and
Cosmetic Act. The definition of "manufacture" would be modified
to exclude foods, drugs, and devices manufactured only for retail
distribution. As a result, the Department of Health estimates
the loss of fee revenue noted below. The reduction in
expenditures would be associated with the reduction in regulatory
activity.
The probable fiscal implication of implementing the provisions of
the bill during each of the first five years following passage
is estimated as follows:
Fiscal Probable Savings Probable Revenue Change in
Year to General Loss from General Number of State
Revenue Fund 001 Revenue Fund 001 Employees from
FY 1995
1996 $1,123,323 $1,123,323 (20.0)
1997 1,123,323 1,123,323 (20.0)
1998 1,123,323 1,123,323 (20.0)
1999 1,123,323 1,123,323 (20.0)
2000 1,123,323 1,123,232 (20.0)
Similar annual fiscal implications would continue as long as the
provisions of the bill are in effect.
No fiscal implication to units of local government is
anticipated.
Source: Department of Health
LBB Staff: JK, KF, DF